MedTrace Logo

Diuretic/Cool Dialysate Trial

NCT02593526 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2024-01-11

Study results available
· View outcomes & findings →

Summary

The proposed pilot study challenges the current widespread paradigm of discontinuing loop diuretics when initiating chronic HD and/or maintaining the dialysate at a constant temperature of 37 °C for all patients.

Conditions

  • Chronic Kidney Insufficiency

Interventions

DRUG

Bumetanide

Diuretic

OTHER

Cool Dialysate

Cool dialysate (35°C)

Sponsors & Collaborators

  • Dialysis Clinic, Inc.

    collaborator INDUSTRY

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Mark L Unruh, MD · University of New Mexico

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2022-05-27
Completion
2022-05-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02593526 on ClinicalTrials.gov